Polar Capital Holdings PLC Vericel Corp Transaction History

Polar Capital Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $201,664 - $347,712	-8,814 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $264,484 - $361,298	-8,346 Reduced 48.64%	8,814 $337,000
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $307,995 - $397,038	6,645 Added 63.2%	17,160 $837,000
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $496,308 - $713,022	10,515 New	10,515 $552,000
Q1 2021 May 17, 2021	SELL	$30.93 - $59.48 $399,244 - $767,767	-12,908 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $239,185 - $406,602	12,908 New	12,908 $399,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.